Ireland· IE-PA-EU/1/20/1528/040-041
COMIRNATY KP.2 10 micrograms/dose dispersion for injection children 5 to 11 years
A covid-19, rna-based vaccine product containing single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2, registered in Ireland by BioNTech Manufacturing GmbH. The same ATC class is registered in 11 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Covid-19, rna-based vaccine is registered in 11 of 19 countries.
Countries holding a registration under ATC J07BN01 (covid-19, rna-based vaccine), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 7 of them publish a price we can compare per daily dose
Covid-19, rna-based vaccine · ATC J07BN01
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
HPRA (Ireland)- Active substance
- Single-stranded, 5’-capped messenger RNA produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2
- Manufacturer
- BioNTech Manufacturing GmbH
- Country
- Ireland (IE)
- ATC code
- J07BN01
- ATC class
- Covid-19, RNA-based vaccine
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/20/1528/040-041
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Covid-19, rna-based vaccine in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainCOMIRNATY 10 MICROGRAMOS/DOSIS CONCENTRADO PARA DISPERSION INYECTABLEBiontech Manufacturing Gmbh
- FinlandComirnatyBioNTech Manufacturing GmbH
- FranceCOMIRNATY 10 microgrammes/dose, dispersion à diluer pour dispersion injectable.Vaccin à ARNm (à nucléoside modifié) contre la COVID-19BIONTECH MANUFACTURING (ALLEMAGNE)
- IcelandCOMIRNATY KP.2BioNTech Manufacturing GmbH
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c6af8444-58c1-4b78-b56c-68fc2aca411c GET /v1/drugs/c6af8444-58c1-4b78-b56c-68fc2aca411c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Dispersion for injection",
"routes": null,
"source": "hpra",
"atc_all": [
"J07BN01"
],
"strength": null,
"pa_number": "EU/1/20/1528/040-041",
"substances": [
"Single-stranded, 5’-capped messenger RNA produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2"
],
"legal_basis": "New active substance (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "21/12/2020",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about covid-19, rna-based vaccine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.